Effects of Clopidogrel on Mortality, Cardiovascular and Bleeding Outcomes in Patients with Chronic Kidney Disease - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry-Reference-Cited by-同舟云学术

Effects of Clopidogrel on Mortality, Cardiovascular and Bleeding Outcomes in Patients with Chronic Kidney Disease - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry

Published:2013-08-28 Issue:8 Volume:8 Page:e71917
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lin Tsung-Hsien,Lai Wen-Ter,Hsin Ho-Tsung,Li Ai-Hsien,Wang Chun-Li,Kuo Chi-Tai,Hwang Juey-Jen,Chiang Fu-Tien,Chang Shu-Chen,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol;MA Nordlie,2005

2. Taiwan Department of Health. Statistics data. Statistical analysis of 2009 mortality data. Press conference on 2009 mortality data. Available: http://www.doh.gov.tw. Accessed 2011 Jan 19.

3. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J;A Budaj,2009

4. Prognostic importance of bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients. JACC Interv;MS Lindsey JB,2009

5. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med;SD Wiviott,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and Study Design of the TSOC-Fully Organized Registry for the Management of Symptomatic ACS Study (T-FORMOSA Study);ACTA CARDIOL SIN;2023

2. Antiplatelet for Coronary Artery Disease in Specific Condition “No Size Fits All”;Current Pharmaceutical Design;2018-04-24

3. The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry;ACTA CARDIOL SIN;2017

4. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease;Kidney International;2017-01

5. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease;European Journal of Internal Medicine;2016-09